Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: Development and utility of a potential diagnostic immunohistochemistry panel

BMC Clinical Pathology

Volumn 14, Issue 1, 2014, Pages

  Ali, Asif ^a   Brown, Victoria ^b   Denley, Simon ^c   Jamieson, Nigel B ^c   Morton, Jennifer P ^d   Nixon, Colin ^d   Graham, Janet S ^e   Sansom, Owen J ^d   Carter, C Ross ^c   McKay, Colin J ^c   Duthie, Fraser R ^f   Oien, Karin A ^a,f  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^e BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^f SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Diagnosis; Immunohistochemistry; Pancreatic cancer

Indexed keywords

EID: 84904522673     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-14-35     Document Type: Article

References (60)

1. Cancer Research UK. London, News and Resources [cited 2012April24]. Pancreatic cancer statistics- Key facts Available from: http://info. cancerresearchuk.org/cancerstats/keyfacts/pancreatic-cancer/
2. Pancreatic cancer. Hidalgo M, N Engl J Med 2010 362 17 1605 1617
3. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, Zheng H, Szymonifka J, Wargo JA, Thayer SP, Lauwers GY, Deshpande V, Mino-Kenudson M, Fernández-del Castillo C, Lillemoe KD, Warshaw AL, Surgery 2012 152 3 Suppl 1 43 S49
4. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M, World J Surg 2003 27 3 324 329 (Pubitemid 36920145)
5. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Jang JY, Kim SW, Kang GH, Yoon YB, Ann Surg Oncol 2007 14 11 3195 3201 (Pubitemid 47594288)
6. Pancreatic adenocarcinoma. Bond-Smith G, Banga N, Hammond TM, Imber CJ, Br Med J 2012 344 2476
7. Diagnostic management of pancreatic cancer. Dabizzi E, Assef MS, Raimondo M, Cancer 2011 3 1 494 509
8. Pancreatic head cancer: accuracy of CT in determination of resectability. Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A, Abdom Imaging 2005 30 4 488 500 (Pubitemid 41176128)
9. Diagnosis of pancreatic cancer. Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K, HPB 2006 8 5 337 342 (Pubitemid 44473457)
10. Diagnosis of cholangiocarcinoma. Van Beers BE, HPB 2008 10 2 87 93 (Pubitemid 351934991)
11. Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology. Adler D, Max Schmidt C, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, Romagnuolo J, Shaaban AM, Simeone D, Bishop Pitman M, Field A, Layfield LJ, Diagn Cytopathol 2014 42 4 325 332
12. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors. Chang KJ, Endoscopy 2006 38 Suppl 1 56 S60
13. Endoscopic-ultrasound-guided fine-needle aspiration and the role of the cytopathologist in solid pancreatic lesion diagnosis. Iqbal S, Friedel D, Gupta M, Ogden L, Stavropoulos SN, Pathol Res Int 2012 2012 317167
14. Influence of the safety and diagnostic accuracy of preoperative endoscopic ultrasound-guided fine-needle aspiration for resectable pancreatic cancer on clinical performance. Kudo T, Kawakami H, Kuwatani M, Eto K, Kawahata S, Abe Y, Onodera M, Ehira N, Yamato H, Haba S, Kawakubo K, Sakamoto N, World J Gastroenterol 2014 20 13 3620 3627
15. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB, J Gastrointest Surg 2003 7 1 118 126 discussion 127-118
16. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR, J Clin Pathol 2001 54 6 449 455 (Pubitemid 32531094)
17. Comparative study of diagnostic value of cytologic sampling by endoscopic ultrasonography-guided fine-needle aspiration and that by endoscopic retrograde pancreatography for the management of pancreatic mass without biliary stricture. Wakatsuki T, Irisawa A, Bhutani MS, Hikichi T, Shibukawa G, Takagi T, Yamamoto G, Takahashi Y, Yamada Y, Watanabe K, Obara K, Suzuki T, Sato Y, J Gastroenterol Hepatol 2005 20 11 1707 1711 (Pubitemid 43961077)
18. Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Yoshinaga S, Suzuki H, Oda I, Saito Y, Dig Endosc 2011 23 Suppl 1 29 33
19. Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses. Harewood GC, Wiersema LM, Halling AC, Keeney GL, Salamao DR, Wiersema MJ, Gastrointest Endosc 2002 55 6 669 673 (Pubitemid 41123468)
20. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L, Am J Gastroenterol 2004 99 5 844 850 (Pubitemid 39090211)
21. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N, Vickers SM, Wilcox CM, Am J Gastroenterol 2003 98 12 2663 2668 (Pubitemid 38020105)
22. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Horwhat JD, Paulson EK, McGrath K, Branch MS, Baillie J, Tyler D, Pappas T, Enns R, Robuck G, Stiffler H, Jowell P, Gastrointest Endosc 2006 63 7 966 975 (Pubitemid 43776157)
23. Endoscopic ultrasound guided fine needle aspiration biopsy in diagnosis of pancreatic and peripancreatic lesions: a single center experience in Korea. Hwang CY, Lee SS, Song TJ, Moon SH, Lee D, Park do H, Seo DW, Lee SK, Kim MH, Gut Liver 2009 3 2 116 121
24. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient-management strategy. Touchefeu Y, Le Rhun M, Coron E, Alamdari A, Heymann MF, Mosnier JF, Matysiak T, Galmiche JP, Aliment Pharmacol Ther 2009 30 10 1070 1077
25. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Varadarajulu S, Tamhane A, Eloubeidi MA, Gastrointest Endosc 2005 62 5 728 736 quiz 751, 753 (Pubitemid 41503000)
26. Pancreatic cytopathology: a practical approach and review. Bellizzi AM, Stelow EB, Arch Pathol Lab Med 2009 133 3 388 404
27. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Logrono R, Kurtycz DF, Molina CP, Trivedi VA, Wong JY, Block KP, Arch Pathol Lab Med 2000 124 3 387 392 (Pubitemid 30152140)
28. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Krishna NB, Mehra M, Reddy AV, Agarwal B, Gastrointest Endosc 2009 70 1 70 79
29. Standardization in immunohistochemistry: the role of antigen retrieval in molecular morphology. Taylor CR, Biotech Histochem 2006 81 1 3 12 (Pubitemid 43879085)
30. Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma. Agarwal B, Ludwig OJ, Collins BT, Cortese C, Clin Gastroenterol Hepatol 2008 6 12 1425 1431
31. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U, Cancer 2003 99 6 365 371 (Pubitemid 38017536)
32. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Deng H, Shi J, Wilkerson M, Meschter S, Dupree W, Lin F, Am J Clin Pathol 2008 129 1 81 88 (Pubitemid 352038597)
33. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation. Giorgadze TA, Peterman H, Baloch ZW, Furth EE, Pasha T, Shiina N, Zhang PJ, Gupta PK, Cancer 2006 108 3 186 197
34. Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. Jhala N, Jhala D, Vickers SM, Eltoum I, Batra SK, Manne U, Eloubeidi M, Jones JJ, Grizzle WE, Am J Clin Pathol 2006 126 4 572 579
35. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology. Kosarac O, Takei H, Zhai QJ, Schwartz MR, Mody DR, Acta Cytol 2011 55 2 142 148
36. KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies. Ligato S, Zhao H, Mandich D, Cartun RW, Diagn Cytopathol 2008 36 8 561 567
37. Expression of K homology domain containing protein (KOC) in pancreatic cytology with corresponding histology. Toll AD, Witkiewicz AK, Bibbo M, Acta Cytol 2009 53 2 123 129
38. Abstract 1142: systematic review and meta-analysis of immunohistochemical diagnostic markers for pancreatic ductal adenocarcinoma. Ali A, Ul-Haq Z, Mohamed M, MacKay DF, Duthie F, Oien K, Cancer Res 2013 73 8 Supplement 1142
39. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Cancer 2001 91 7 1332 1341 (Pubitemid 32267045)
40. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM, Am J Surg Pathol 2005 29 3 359 367 (Pubitemid 40321972)
41. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Hassan R, Laszik ZG, Lerner M, Raffeld M, Postier R, Brackett D, Am J Clin Pathol 2005 124 6 838 845 (Pubitemid 41740183)
42. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani P, Hum Pathol 2004 35 3 357 366 (Pubitemid 38339611)
43. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J, McKay CJ, J Gastrointest Surg 2013 17 5 887 898
44. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. Yantiss RK, Cosar E, Fischer AH, Acta Cytol 2008 52 2 133 138 (Pubitemid 351441122)
45. Prognostic significance of maspin in pancreatic ductal adenocarcinoma. Lim YJ, Lee JK, Jang WY, Song SY, Lee KT, Paik SW, Rhee JC, Kor J Intern Med 2004 19 1 15 18 (Pubitemid 41237483)
46. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W, Nagasaki K, Clin Cancer Res 2001 7 4 812 817 (Pubitemid 32708715)
47. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K, Am J Surg Pathol 2005 29 2 188 195 (Pubitemid 40170636)
48. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-With implication of their roles in early tumorigenesis. Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW, Brown RE, Zhang J, Wang HL, Schuerch C, Am J Surg Pathol 2008 32 1 78 91
49. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Clin Cancer Res 2001 7 12 3862 3868 (Pubitemid 34044602)
50. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, Van Heek NT, Hruban RH, Wilentz RE, Appl Immunohistochem Mol Morphol 2003 11 3 238 243 (Pubitemid 37082060)
51. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas. Wang Y, Gao J, Li Z, Jin Z, Gong Y, Man X, Int J Cancer 2007 121 12 2716 2722 (Pubitemid 350136417)
52. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Awadallah NS, Shroyer KR, Langer DA, Torkko KC, Chen YK, Bentz JS, Papkoff J, Liu W, Nash SR, Shah RJ, Pancreas 2008 36 2 200 206
53. CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections. Boltze C, Schneider-Stock R, Aust G, Mawrin C, Dralle H, Roessner A, Hoang-Vu C, Pathol Int 2002 52 2 83 88 (Pubitemid 34298094)
54. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Cao D, Zhang Q, Wu LSF, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L, Mod Pathol 2007 20 5 570 578 (Pubitemid 46631999)
55. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S, Diagn Cytopathol 2007 35 3 143 147 (Pubitemid 46355345)
56. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P, Am J Clin Pathol 2002 117 5 791 796 (Pubitemid 34457016)
57. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Zhao H, Mandich D, Cartun RW, Ligato S, Diagn Cytopathol 2007 35 11 700 704 (Pubitemid 350035041)
58. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Cancer Res 2001 61 11 4320 4324 (Pubitemid 32685751)
59. Double immunohistochemical staining with MUC4/p53 is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray-based study. Bhardwaj A, Marsh WL Jr, Nash JW, Barbacioru CC, Jones S, Frankel WL, Arch Pathol Lab Med 2007 131 4 556 562 (Pubitemid 46564427)
60. Application of mesothelin immunostaining in tumor diagnosis. Ordonez NG, Am J Surg Pathol 2003 27 11 1418 1428 (Pubitemid 37315193)